NCT07780890 A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
| NCT ID | NCT07780890 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Fuchs Endothelial Corneal Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-08-18 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2026-08-18 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.
Eligibility Criteria
Inclusion Criteria: * Healthy volunteers with normal eyes * Visual acuity between +2 to -6 diopters Exclusion Criteria: * History of refractive or cataract surgery * History of ocular disease * Active non-ophthalmic systemic disease
Contact & Investigator
Seok-Hyun Yun, PhD
PRINCIPAL INVESTIGATOR
Massachusetts General Brigham
Frequently Asked Questions
Who can join the NCT07780890 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 79 Years, studying Fuchs Endothelial Corneal Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07780890 currently recruiting?
Yes, NCT07780890 is actively recruiting participants. Contact the research team at sahn14@mgh.harvard.edu for enrollment information.
Where is the NCT07780890 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07780890 clinical trial?
NCT07780890 is sponsored by Massachusetts General Hospital. The principal investigator is Seok-Hyun Yun, PhD at Massachusetts General Brigham. The trial plans to enroll 90 participants.